3D-quantitative structure–activity relationship and antiviral effects of curcumin derivatives as potent inhibitors of influenza H1N1 neuraminidase

[1]  Matthieu J. Miossec,et al.  Integration of target discovery, drug discovery and drug delivery: A review on computational strategies. , 2019, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[2]  Aleksandar M. Veselinovic,et al.  The anesthetic action of some polyhalogenated ethers - Monte Carlo method based QSAR study , 2018, Comput. Biol. Chem..

[3]  Yi-lin Li,et al.  Synergic effect of curcumin and its structural analogue (Monoacetylcurcumin) on anti-influenza virus infection , 2018, Journal of food and drug analysis.

[4]  S. Kannan,et al.  Antiviral potential of natural compounds against influenza virus hemagglutinin , 2017, Comput. Biol. Chem..

[5]  P. Zhan,et al.  3D-QSAR analysis of a series of S-DABO derivatives as anti-HIV agents by CoMFA and CoMSIA , 2016, SAR and QSAR in environmental research.

[6]  T. Tumpey,et al.  Oseltamivir inhibits influenza virus replication and transmission following ocular-only aerosol inoculation of ferrets. , 2015, Virology.

[7]  Y. Mizushina,et al.  Structure–activity relationship analysis of curcumin analogues on anti‐influenza virus activity , 2013, The FEBS journal.

[8]  Hiroshi Ohrui,et al.  Functional and Structural Analysis of Influenza Virus Neuraminidase N3 Offers Further Insight into the Mechanisms of Oseltamivir Resistance , 2013, Journal of Virology.

[9]  Hyun-kyung Lee,et al.  Oseltamivir-resistant influenza viruses isolated in South Korea from 2005 to 2010 , 2013, Archives of Virology.

[10]  E. Jho,et al.  Oseltamivir-resistant influenza viruses isolated in South Korea from 2005 to 2010 , 2013, Archives of Virology.

[11]  W. Hsu,et al.  Inhibition of Enveloped Viruses Infectivity by Curcumin , 2013, PloS one.

[12]  P. Palese,et al.  Toward a universal influenza virus vaccine: prospects and challenges. , 2013, Annual review of medicine.

[13]  M. Casarotto,et al.  Design and synthesis of pinanamine derivatives as anti-influenza A M2 ion channel inhibitors. , 2012, Antiviral research.

[14]  Guan-Hua Du,et al.  3D QSAR and docking study of flavone derivatives as potent inhibitors of influenza H1N1 virus neuraminidase. , 2011, Bioorganic & medicinal chemistry letters.

[15]  Hui Wang,et al.  Synergistic activity of baicalein with ribavirin against influenza A (H1N1) virus infections in cell culture and in mice. , 2011, Antiviral research.

[16]  Jiansong Fang,et al.  A New Protocol for Predicting Novel GSK-3β ATP Competitive Inhibitors , 2011, J. Chem. Inf. Model..

[17]  A. Moscona,et al.  Global transmission of oseltamivir-resistant influenza. , 2009, The New England journal of medicine.

[18]  S. Mossad,et al.  The First Pandemic of the 21st Century: Review of the 2009 Pandemic Variant Influenza A (H1N1) Virus , 2009, Postgraduate medicine.

[19]  A. Kelso,et al.  Zanamivir-Resistant Influenza Viruses with a Novel Neuraminidase Mutation , 2009, Journal of Virology.

[20]  Gavin J. D. Smith,et al.  Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic , 2009, Nature.

[21]  B. Aggarwal,et al.  Curcumin as "Curecumin": from kitchen to clinic. , 2008, Biochemical pharmacology.

[22]  J. Taubenberger,et al.  The pathology of influenza virus infections. , 2008, Annual review of pathology.

[23]  Robert A Newman,et al.  Bioavailability of curcumin: problems and promises. , 2007, Molecular pharmaceutics.

[24]  Thorsten Wolff,et al.  Acetylsalicylic acid (ASA) blocks influenza virus propagation via its NF‐κB‐inhibiting activity , 2007, Cellular microbiology.

[25]  T. Sakai,et al.  Roles of neuraminidase in the initial stage of influenza virus infection. , 2006, Microbes and infection.

[26]  A. Singh,et al.  Multiple biological activities of curcumin: a short review. , 2006, Life sciences.

[27]  W. Fiers,et al.  A "universal" human influenza A vaccine. , 2004, Virus research.

[28]  Gefei Wang,et al.  Inhibition of curcumin on influenza A virus infection and influenzal pneumonia via oxidative stress, TLR2/4, p38/JNK MAPK and NF‐&kgr;B pathways , 2018, International immunopharmacology.

[29]  Jianhui Xie,et al.  Oral administration of patchouli alcohol isolated from Pogostemonis Herba augments protection against influenza viral infection in mice. , 2012, International immunopharmacology.

[30]  Neerja Kaushik-Basu,et al.  3D QSAR and Molecular Docking Studies of Benzimidazole Derivatives as Hepatitis C Virus NS5B Polymerase Inhibitors , 2008, J. Chem. Inf. Model..

[31]  H. Oshitani,et al.  Emergence of amantadine-resistant influenza A viruses: epidemiological study , 2003, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[32]  A. Tropsha,et al.  Beware of q2! , 2002, Journal of molecular graphics & modelling.

[33]  A. Tropsha,et al.  Beware of q 2 , 2002 .

[34]  Ramaswamy Nilakantan,et al.  New method for rapid characterization of molecular shapes: applications in drug design , 1993, J. Chem. Inf. Comput. Sci..

[35]  M. A. Jabbar,et al.  Structural domains and organizational conformation involved in the sorting and transport of influenza virus transmembrane proteins. , 1989, Annual review of microbiology.